Elanco director awarded stock and RSU grants

Kurzius Lawrence Erik reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Kurzius Lawrence Erik reported acquisition or exercise transactions in this Form 4 filing.

Elanco Animal Health Inc director Lawrence Erik Kurzius reported two equity awards of common stock on May 21, 2026. He received 12,196 deferred stock units as a pro-rated annual equity award and 4,678 restricted stock units as an annual equity grant for non-employee directors.

Both awards were recorded at $0.00 per share, reflecting compensation grants rather than open-market purchases.

Insider Trade Summary

Grant/Award: 16,874 shares

Grant/Award 2 txns

Insider Kurzius Lawrence Erik

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	4,678	$0.00	$0.00
Grant/Award	Common Stock	12,196	$0.00	$0.00

Holdings After Transaction: Common Stock — 148,647 shares (Direct)

Footnotes (2)

1. F1. Grant of deferred stock units as a pro-rated annual equity award to each of the non-employee members of the Issuer's Board of Directors.
2. F2. Grant of restricted stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.

Key Figures

Deferred stock units granted: 12,196 units Restricted stock units granted: 4,678 units Transaction code: A (Grant, award, or other acquisition) +1 more

4 metrics

Deferred stock units granted 12,196 units Pro-rated annual equity award on May 21, 2026

Restricted stock units granted 4,678 units Annual equity award on May 21, 2026

Transaction code A (Grant, award, or other acquisition) Both non-derivative transactions on May 21, 2026

Reported price per share $0.00 per share For both equity grants reported in the Form 4

Key Terms

deferred stock units, restricted stock units, annual equity award, non-employee members of the Issuer's Board of Directors

4 terms

deferred stock units financial

"Grant of deferred stock units as a pro-rated annual equity award"

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

restricted stock units financial

"Grant of restricted stock units as an annual equity award"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

annual equity award financial

"as a pro-rated annual equity award to each of the non-employee members"

non-employee members of the Issuer's Board of Directors financial

"to each of the non-employee members of the Issuer's Board of Directors"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Elanco (ELAN) director Lawrence Erik Kurzius report in this Form 4?

He reported receiving two equity awards of Elanco common stock as board compensation. The filing shows grants of deferred stock units and restricted stock units, rather than any open-market purchases or sales of shares.

How many Elanco (ELAN) deferred stock units were granted to director Kurzius?

He received 12,196 deferred stock units as a pro-rated annual equity award. These units are compensation for serving as a non-employee member of Elanco’s Board of Directors, not shares bought in the open market.

How many restricted stock units did Elanco (ELAN) grant to Kurzius?

He was granted 4,678 restricted stock units as an annual equity award. These RSUs are part of Elanco’s compensation program for non-employee directors and were recorded at a price of $0.00 per share in the Form 4.

Were Kurzius’s Elanco (ELAN) Form 4 transactions open-market trades?

No, the transactions reflect compensation-related equity grants, not market trades. Both entries use transaction code A, described as a grant, award or other acquisition, and are tied to the company’s non-employee director equity program.

What do the footnotes in the Elanco (ELAN) Form 4 say about these grants?

The footnotes explain that 12,196 units are deferred stock units and 4,678 are restricted stock units. Both are annual equity awards granted to each non-employee member of Elanco’s Board of Directors as part of their regular compensation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/26/2026 - 04:47 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kurzius Lawrence Erik

(Last) (First) (Middle)

C/O ELANCO ANIMAL HEALTH INCORPORATED

450 ELANCO CIRCLE

(Street)

INDIANAPOLIS INDIANA 46221

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/21/2026		A		4,678(1)	A	$0	136,451	D
Common Stock	05/21/2026		A		12,196(2)	A	$0	148,647	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of deferred stock units as a pro-rated annual equity award to each of the non-employee members of the Issuer's Board of Directors.

2. Grant of restricted stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.

	/s/ Amy C. Seidel, as Attorney-in-Fact for Lawrence Kurzius	05/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)